$ELV News

Elevance Health (ELV) After Its Cancer Care Push, Does The Valuation Still Look Attractive##

Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giant

Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey

Investors’ Favour Strengthens Elevance Health’s (ELV) Rebound

Elevance Health Has Upside, But Not Yet A Buy

Elevance Health Pick of the Week at Smart Insider Following CEO, Chairman Share Purchases

Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run

Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?

Elevance Health CEO Snaps Up Stock After Post-Earnings Slide

Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?

Leerink Partners Maintains Market Perform on Elevance Health, Raises Price Target to $395

Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive

RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings

Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455

Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $457

Baird Maintains Neutral on Elevance Health, Raises Price Target to $393

Elevance Health (ELV) Beats Q2 And Raises Outlook While Leaving More Medicaid Markets

Elevance Health (ELV) Q2 2026 Earnings Call Transcript